Filing Details
- Accession Number:
- 0000899243-21-011747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-15 21:08:10
- Reporting Period:
- 2021-03-11
- Accepted Time:
- 2021-03-15 21:08:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1815442 | Kymera Therapeutics Inc. | KYMR | Biological Products, (No Disgnostic Substances) (2836) | 812992166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821074 | N. Bruce Jacobs | C/O Kymera Therapeutics, Inc. 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-11 | 1,805 | $2.08 | 1,805 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-11 | 1,805 | $60.07 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-03-15 | 8,195 | $2.08 | 8,195 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-15 | 8,195 | $60.17 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-11 | 1,805 | $0.00 | 1,805 | $2.08 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-15 | 8,195 | $0.00 | 8,195 | $2.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 242,256 | 2030-08-19 | No | 4 | M | Direct | |
| 234,061 | 2030-08-19 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.675. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date
Billionaire Hedge Funds
